This stlldy iJ17'cstlgated insulin adsorptiL'e loss occurring ill 'i'arlolts infusion systemsltsed III regimens of parenteral nZ/trition. The reS1tlts suggested early and considerable inslllin loss in dextrose infllsion solutions with doses of insulin used clinically. J1 aximlllll percentage loss occurred within 30 seconds following administration of insulin to infusion bottles of 5% and 50% dextrose. J1 ean il1sulin loss over eight hours amounted to 47·6% ±2· 0 s.e.m. in 5% dextrose and 34·8% :1=1·5 s.e.m. in 50% dextrose. The combination of infusion bottle andinfl/sioll set further increased the mean insulin loss in 50(>~ dextrose to 43·6% :-'c1· 7 s.c.m.
where it has been infused in various of the nutrient solutions. Adequate insulin must be given to ensure glucose utilization when hypertonic glucose solutions arc used (Lee ] 97ri) and in sen:re burns, for example, insulin in conjunction ,,-ith hypertonic glucose solutions has been sho\\,11 to reverse the marked nitrogen catabolism \\'hich occurs (Hinton et al. 1971) .
The concentrations of insulin used in thest' various nutrient solutions have been extremely variable and have ranged from 10\\' levels of If) to 2i5 units per 1000 calories (Dudrick et al. 1 H72) to high levels of GO to 300 unib per J 000 calories (Hinton et al. 1971 ). Insulin admini,;tration by such intravenous solution,; b complicated however, by observations indicating that insulin is variably adsorbed onto glass and plastic surfaces. For example, signiticant adsorption of insulin onto laboratory glassware has been shO\m to occur (Hill 19'-; 9a, Hill 1959b, \Viseman and Baltz 19ti1) and insulin adsorption onto plastic infusion sets and plastic or glass infusion bottles containing isotonic solutions has also been documented (Weisenfeld et al. 19G8, Petty and Cunningham 197 cl) .
Anaesthesia and Intensive Care, Vol. IV, 1\'(1. 4, r:ovcmber, 1!),lj Accordingly, the present study was undertaken in order to examine the extent and nature of adsorptive insulin loss occurring in various infusion systems used clinically for parenteral nutrition.
METHODS
In all experiments which were performed at 22°C, known amounts of soluble insulin (Insulin B.P. 40 units/ml, Commonwealth Serum Laboratories) were injected into conventional 500 ml glass bottles of infusates, using a 1·0 ml polypropylene syringe (Jintan Terumo) and a 26-gauge disposable needle. The solutions were mixed in a standard manner by inverting the bottles five times and shaking them horizontally twice. Following suspension of the bottles in the inverted position, samples of the contents were collected by intermittent gravity drainage through a 16-gauge cannula (Medicut, Sherwood Medical Industries) and a 3-way plastic stopcock, into standard 10 ml polypropylene assay tubes.
The insulin concentration in each sample was determined in triplicate by means of a sequential equilibrium technique, employing an insulin immunoassay kit (Radiochemical Centre, Amersham). The principle of the method was based on that of Hales and Randle (1963) and briefly the technique involved the competition of sample insulin and added 125I-insulin for insulin specific antibody. Radioactivity of the solid phase, measured in a scintillation counter (Nuclear Chicago), was inversely related to the amount of insulin in the sample. Initial studies had shown that adsorption of insulin to the polypropylene assay tubes was less than 2%.
The percentage loss of insulin occurring on account of adsorption to the infusion bottles or infusion systems was determined under a number of different experimental conditions. The effect of varying the time of contact of the insulin with the container was examined in eight experiments in which insulin was injected separately into four bottles of 5% dextrose (Venosol, Abbott Laboratories) and also into four bottles of 50% dextrose (Venosol, Abbott Laboratories) to achieve a final concentration of 80 units/litre. Samples were collected for insulin assay at time intervals after injection of 0'5,2,5, J 0 and 30 minutes and then 1, 2, 4 and 8 hours post-injection. In order to determine the total insulin loss due to the combination of infusion bottle and infusion set, insulin was added to five bottles of 50% dextrose to produce the same final concentration of 80 units/litre and samples were collected for assay (at the same time intervals up to eight hours) after the dextrose solution had been infused through the attached plastic infusion sets (Travenol, AH2053) at a fixed flow rate of 1· 0 ml/min.
In two groups of experiments, insulin loss in infusion bottles of 5% dextrose and 50% dextrose was determined under the circumstances of increasing insulin concentration. Using five bottles of 5% dextrose and also 50% dextrose for each insulin concentration, insulin was added to achieve final concentrations respectively of 20, 40, 80, 160 and 240 units/ litre. Assay samples were taken 30 minutes after insulin administration.
The possible action of serum albumin in inhibiting insulin loss due to adsorption was investigated using five bottles of 50% dextrose into which serum albumin (Normal Human Serum Albumin Concentrated~25%, Commonwealth Serum Laboratories) had been added in a concentration of 0 '05% w/v followed by insulin in a final concentration of 80 units/litre. Samples for insulin assay were taken at time intervals of 0 ·5,15 and 30 minutes following the addition of insulin. The effect of competing proteins on insulin adsorption was also examined using nutrient solutions of Aminofusin 600 (Fawns and McAllan). In five bottles of Aminofusin 600, to which insulin had been added in a final concentration of 80 units/litre, samples were obtained for assay at 0 '5, 15 and 30 minutes after insulin administration.
ANALYSIS OF RESULTS
Analyses of variance computations were performed on a DEC System-JO Computer. Significance was assessed at the 5% level.
Student's t-test was also used to evaluate statistical significance. Figure 1 j]]ustrates the percentage insulin adsorption to glass infusion bottles containing either 5% dextrose or 50% dextrose at time periods up to eight hours. Examination of percentage insulin loss due to adsorption in the bottles of 5% dextrose at the various times by analysis of variance, showed no significant difference between the percentage losses occurring at the different times (Variance Ratio 0·709; Degrees of Freedom 9/24). Insulin loss was therefore independent of time of contact with the glass container; maximum loss occurred within 30 seconds following administration of insulin to the infusion bottle and the mean loss over eight hours was 47·6%±2·0 s.e.m. The results with the 50% dextrose over the same period of time were similar in that analysis of variance showed no significant difference between groups of values (V.R. 0 ·564 ; D.F. 9/2S). Except for an overall mean insulin loss of 34 'S% ±1·5 s.e.m. which was significantly less than that occurring with 5% dextrose (P <0 ·0005) the conclusions in this case were the same as those for 5% dextrose. significant difference between percentage insulin loss occurring at the different times (V.R. 0·446; 9/29). The overall mean loss due to the combined effect of the infusion bottle and infusion set was 43·6% ±1'7 s.e.m. which was significantly greater than that (34 'S% ±1·5 s.e.m.) occurring due to the infusion bottle alone (P<0·0005). The results of the experiments investigating the effect of increasing insulin concentration on the percentage loss of insulin in solutions of 5% dextrose and 50% dextrose, respectively, are shown in Figure 3 . Percentage insulin loss in bottles of 5% dextrose clearly decreased as the concentration of insulin increased. An unexpected finding, however, was that insulin loss in 50% dextrose was unaffected by varying the insulin concentration. Analysis of variance of the percentage loss at each insulin concen tration showed no significant difference between groups (V.R. 2 ·013; D.F. 4/1S), and the mean loss was 32·2%±1·3 s.e.m . Figure 4 shows the insulin loss occurring with insulin (80 units/litre) in 50% dextrose compared with that occurring in 50% dextrose solution to which human serum albumin 0 ,05% w/v had been added previously. Insulin loss within either group at sampling times of 0 '5, 15 and 30 minutes after insulin administration showed no significant difference by analysis of variance; (V.R. 0 ,950; D.F. 2/S) for 50% dextrose and (V.R. l'S17 ; D.F. 2/11) for 50% dextrose with added albumin. The overall mean percentage loss of insulin in 50% dextrose at the three different sampling times was 35 '6% ±2'9 s.e.m. and that for 50% dextrose with added albumin was 28·4%±1·8 s.e.m. The effect of the added albumin was to lessen insulin loss to a small but significant degree (P<0·025). The results of insulin adsorption to glass in the nutrient solutions of Aminofusin 600 are also illustrated in Figure 4 . In a final concentration of 80 units/litre, insulin loss at the sampling times of 0·5, 15 and 30 minutes showed no significant difference by analysis of variance (V.R. 0 ,321; D.F. 2/12). As with all of the preceding nutrient solutions, insulin loss (at one insulin concentration) in Aminofusin 600 was unaffected by contact time following administration to the infusion bottles. Mean insulin loss in Aminofusin 600 over the 30-minutes period was 14·0%±1·6 s.e.m.
RESULTS

DISCUSSION
The physical adsorption of insulin onto laboratory glassware (Hill 1959a , Hill 1959b , Wiseman and Baltz 1961 and onto glass and plastic intravenous infusion systems accounting for insulin loss in isotonic solutions (Weisenfeld et al. 1968, Petty and Cunningham 1974 ) is a non-specific surface phenomenon which occurs on otherwise inert surfaces (Hill 1959b , Weisenfeld et al. 1968 ). The present study examined the percentage loss of insulin due to adsorption in infusion solutions such as 5% and 50% dextrose which are commonly used in regimens of parenteral nutrition. The data showed early and considerable insulin loss in the dextrose infusion systems with doses of insulin which are used clinically. The duration of insulin contact (at a concentration of 80 units/litre) did not affect the degree of adsorption after the first 30 seconds and there was overall significantly less insulin loss in infusion bottles of 50% dextrose (35%) than in the bottles of 5% dextrose (48%). Passage of insulin through the plastic tubing of the 50% glucose infusion system accounted for a further loss of 9% amounting to a total insulin loss of 44% for the entire system. The percentage decrease in insulin loss due to adsorption, seen with increasing concentrations of insulin in 5% dextrose did not occur with solutions of 50% dextrose where percentage insulin loss was independent of insulin concentration over the insulin concentration range of 20 to 240 units/ litre .
Of the factors which are thought to influence adsorption of insulin and other peptide hormones to inert surfaces, the nature and concentration of competing proteins may also play a significant role (Palmieri, Yalow and Berson 1971) . Insulin loss in the solutions of Aminofusin 600 employed in the present study was noted to be only 14% at an insulin concentration of 80 units/litre, which suggests a high degree of competition of the amino acids for the insulin adsorption sites. Protein-containing media have been effective in preventing insulin loss when used as carrier solutions for low-dose intravenous infusions of neutral insulin in the management of diabetic ketoacidosis (Kidson et al. 1974 , Kraegen et al. 1975 . Human serum albumin added to infusion solutions of Ringer's lactate in a concentration of 0 '025% w/v decreased percentage loss of soluble insulin due to adsorption from 52 to 28%, although it is of interest that a 10-fold increase in albumin concentration (0'25% w/v) failed to further reduce the insulin loss (Petty and Cunningham 1974) . In the present investigation, however, using soluble insulin, addition of human serum albumin in a concentration of 0 '05% had only a small (7%) effect in reducing percentage insulin loss in 50% dextrose solution. The reduced effectiveness of the added albumin in inhibiting insulin loss in the present study may relate to the hypertonic 50% dextrose solution which was used in these experiments. Competition by the large numbers of dextrose molecules in this high dextrose concentration will have already considerably reduced the percentage insulin adsorption and loss, which tends to lessen the effects of further added albumin or other forms of protein.
There has been considerable variation in the quantities of insulin used in the various regimens of parenteral nutrition (Hinton ct al. 19/1, Dudrick ct al. 1972, Hinton et al. 197:{, Stewart and Loewenthal lH74) . Insulin requirements of cuurse vary between patients because of differences in metabolism, insulin response, clinical state and the nutritional regimen chosen. \Yhile the therapeutic significance of the added insulin depends on each individual clinical situation, the clinician should be aware of the extent of potential insulin loss in the infusion system. ;\:; indicated by the results of the current investigation and also by other studies (\\'eisenfeld ct al J 91lH, Petty and Cunningham 197 -!), acborptive insulin loss varies considerably depending on the particular nutrient solution and infusion system employed. \rhibt the additional use of protein solutions may he beneficial in reducing insulin loss in regimens of parenteral nutrition, the~' do introduce another variable into complicated therapeutic situations. :'I1ore consideration should therefore he given to the nature of the infusion solution to ,,'hich insulin is to he added. In any given patient, for example, insulin administratioll should be confined where possihle to the onc type of infusion ,.;olution. In conjunction with the addition of fairly standard amount,.; of illsulin, ,'ariatioll in insuiin loss could be minimized and hetter llH'tabolic control achie\'ed, .\nC\()\\"l,E I )(;E~[E:\TS
